The phenotype of the lung tumor cells we have analyzed in conjunction with the described high frequency of antigen processing machinery abnormalities in tumor cells suggest that defects in this machinery may underlie the HLA class I antigen downregulation we have detected in tumor cells following treatment with tumor antigen-specific CTL. The gene discussed is MICA; the disease is neoplasm.